News for 2011
The Canadian Agency for Drugs and Technologies in Health (CADTH) is an independent agency funded by Canadian federal, provincial, and territorial governments to provide health care decision makers with credible, impartial advice and information about the effectiveness and efficiency of drugs and other health technologies. Unlike regulators who determine which technologies can be used in Canada, CADTH supports decision makers who are exploring what technologies should be used to achieve the best outcomes both on patient health and the health care system.
For details on how to contact CADTH, visit our Contact Us page.
Showcasing CADTH's Work in Self-Monitoring of Blood Glucose
December 09, 2011
Throughout 2010-2011, CADTH hosted 12 Café Scientifique events across Canada, presenting evidence and expert opinion to more than 600 patients, care providers, and decision-makers about ...
CADTH Work Helps Inform Fraser Health’s New Vitamin D Protocol
December 09, 2011
Vitamin D supplementation has been shown to reduce the rate of falls and fractures, and it has other potential health benefits. However, in Canadian long-term care facilities — where falls, ...
British Columbia Ministry of Health Website Features CADTH Work on SMBG
November 29, 2011
The British Columbia Ministry of Health features CADTH’s findings and recommendations on their new web page about self-monitoring of blood glucose (SMBG) for patients with type 2 diabetes ...
CADTH Work Highlighted in CIHI Report on Health Care Cost Drivers
November 23, 2011
CADTH’s contribution to evidence-based health care has been noted in a report from the Canadian Institute for Health Information (CIHI). Health Care Cost Drivers: The Facts discusses the ...
CADTH Signs Agreement with the Pan American Health Organization
November 10, 2011
On October 26, 2011, the Canadian Agency for Drugs and Technologies in Health (CADTH) signed an agreement with the Pan American Health Organization (PAHO), granting PAHO permission to translate ...
Canadian Agency for Drugs and Technologies in Health Appoints Public Member to its Health Technology Expert Review Panel
November 02, 2011
OTTAWA — The Canadian Agency for Drugs and Technologies in Health (CADTH) today announced the appointment of a Public Member to its recently established Health Technology Expert Review ...
CADTH’s Diabetes Virtual Library
November 01, 2011
Just in time for Diabetes Awareness Month, today CADTH launches its updated virtual library of diabetes reports, tools, and other resources — conveniently collecting them in one place.
CADTH Website Survey — Tell Us What You Think
October 24, 2011
We recently unveiled our new website, which was redesigned to better reflect your needs. The revised site reflects CADTH’s transformation, including updated content and a host of exciting ...
CADTH Executive Team Changes
October 17, 2011
The Canadian Agency of Drugs and Technologies in Health (CADTH) wishes to announce the following changes to its Executive Team. Jane Farquharson will be leaving her position as Vice-President, ...
Can We Reliably Benchmark HTA Organizations? Seminar/Webinar by Dr. Michael Drummond
October 14, 2011
In many jurisdictions, health technology assessment has become 'hard-wired' into reimbursement decisions for drugs, devices and other health technologies. Given the significance of these ...
CMAJ Publishes CADTH Paper Examining Cost-Effectiveness of Second-Line Therapy for Type 2 Diabetes
October 12, 2011
CADTH’s work examining the cost-effectiveness of second-line therapy for type 2 diabetes is now featured in the Canadian Medical Association Journal (CMAJ). Type 2 diabetes is a ...
Rx for Change has been updated!
September 16, 2011
The Rx for Change database is a first in class tool for promoting optimal therapy. It provides a unique source of evidence summaries specific to interventions geared towards altering health ...
Canadian Agency for Drugs and Technologies in Health Appoints Core Members to its New Health Technology Expert Review Panel
September 15, 2011
OTTAWA — The Canadian Agency for Drugs and Technologies in Health (CADTH) today announced the appointment of Core Members to its newly established Health Technology Expert Review Panel. ...
Matthew Brougham Appointed CADTH Vice-President, Products and Services
September 15, 2011
Dr. Brian O’Rourke, President and Chief Executive Officer, CADTH, is pleased to announce the appointment of Matthew Brougham, Vice-President, Products and Services. Matthew is responsible ...
CADTH Work Highlighted in Article on Self-Monitoring of Blood Glucose
September 12, 2011
The latest issue (April-June 2011) of British Columbia-based Therapeutics Initiative’s Therapeutics Letter features CADTH’s work, recommendations, and key messages on the ...
Call for Feedback
September 12, 2011
Three draft reports, including draft recommendations, for the project Optimal Warfarin Management for the Prevention of Thromboembolic Events in Patients with Atrial Fibrillation are available ...
Canadian Agency for Drugs and Technologies in Health Appoints Public Members to its New Canadian Drug Expert Committee
September 07, 2011
OTTAWA ― The Canadian Agency for Drugs and Technologies in Health (CADTH) today announced the appointment of two public members to its newly established Canadian Drug Expert Committee (CDEC). ...
Canadian Agency for Drugs and Technologies in Health Appoints Expert Members to its New Canadian Drug Expert Committee
August 31, 2011
OTTAWA — The Canadian Agency for Drugs and Technologies in Health (CADTH) today announced the appointment of the expert members to its newly established Canadian Drug Expert Committee ...
Gender Issues in Health Technology Assessment: Do As I Say, Not As I Do?
July 26, 2011
The latest issue of International Journal of Technology Assessment in Health Care (Volume 27, Issue 3, Cambridge University Press) features an editorial by CADTH’s Chief Scientist, Dr. ...
CADTH launches new website
May 24, 2011
The Canadian Agency for Drugs and Technologies in Health is pleased to unveil our new website. The revised site was designed to better reflect the needs of our users. We’ve ...
CADTH MRI Pilot Project: Reports Released
May 17, 2011
The final report and guidance document for the 1.5 Tesla Magnetic Resonance Imaging Scanners Compared with 3.0 Tesla Magnetic Imagining Scanners pilot project have been released.
CADTH Announces Priority Areas
May 06, 2011
The Canadian Agency for Drugs and Technologies in Health (CADTH) is pleased to announce its priority areas for 2011-2012. Determined by stakeholders and other reliable methods, these priorities ...
Dr. Brian O’Rourke appointed President and Chief Executive Officer of the CADTH
April 21, 2011
Dr. Terry Sullivan, Chair of the Board of Directors is pleased to announce that Dr. Brian O’Rourke has been appointed President and Chief Executive Officer of the Canadian Agency ...
New Articles Call on Health Professionals to Consider Current Evidence When Recommending Self-Monitoring of Blood Glucose
March 28, 2011
In 2009, CADTH examined the clinical and cost-effectiveness evidence regarding self-monitoring of blood glucose (SMBG) and recommended that most patients with type 2 diabetes who are not using ...
Barb Shea, Vice-President of Products and Services, will be leaving CADTH and full-time employment on March 31, 2011
March 28, 2011
Barb Shea, Vice-President of Products and Services, will be leaving CADTH and full-time employment on March 31, 2011. Since joining CADTH in 2003, she has made significant contributions to ...
Webinar on Grey Literature
March 22, 2011
On April 5, 2011, two CADTH staff members will be delivering a webinar on grey literature as part of a free webinar series on grey literature being offered by AcademyHealth. Amanda Hodgson, ...
CADTH Systematic Review Published as Wiki
March 02, 2011
"Second-line therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy: A systematic review and mixed treatment comparisons meta-analysis” has been ...
Call for Feedback on The Economic Value of Innovative Health Technologies Discussion Paper
February 15, 2011
The Canadian Agency for Drugs and Technologies in Health (CADTH) has undertaken the development of a discussion paper to explore the meaning of innovation, trends in health technology ...
Recommendations Help Inform Educational Tools for British Columbia Physicians
February 01, 2011
British Columbia has provided general practitioners in the province with educational tools to help improve the prescribing of proton pump inhibitors (PPIs) and the practice of self-monitoring of ...
Canadian Agency for Drugs and Technologies in Health selected by the Government of Canada to conduct a research project on optimal use of medical isotopes and alternatives
January 25, 2011
Project will help ensure Canadians and health care providers can continue to rely on appropriate and effective diagnostic imaging tests. OTTAWA, ON – The Canadian Agency for Drugs and ...
Introducing CADTH's New Board of Directors
January 05, 2011
CADTH's 13-member Board of Directors is composed of an independent chair; a regional distribution of jurisdictional federal, provincial, and territorial representatives; and a number of ...